Therapeutic Platform Standardization (Global Biotech)
Not Specified
Key Facts
About Noxilizer
Noxilizer is a private company specializing in a novel nitrogen dioxide (NO2) gas sterilization platform for the life sciences industry. Its core innovation is an ultra-low temperature (10-30°C), surface-level sterilization process that addresses critical challenges with sensitive products like prefilled syringes, drug-device combinations, and sensors, where traditional methods like ethylene oxide (EO) or steam can damage products. The company operates through a dual business model of selling proprietary sterilization equipment and offering contract sterilization services, with validation projects underway with several biopharma clients for commercial products. Noxilizer's technology is positioned as a safer, faster, and more product-friendly alternative to established sterilization methods.
View full company profileTherapeutic Areas
Other Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| Collaborative Program with Ferring | PharmaBiome | Research |
| Lighthouse Pilot Product | Cipherome | Pilot |
| Nitric Oxide + Collagen Delivery | Jellagen | Research |
| Undisclosed | Authera | Pre-clinical |
| mRNA Therapeutics Platform Application | Lupagen | Research |
| PHYRAGO | Handa Pharmaceuticals | Approved |
| TASCENSO ODT | Handa Pharmaceuticals | Approved |
| Axulin | Housey Pharmaceutical Research Laboratories | Commercial |
| PBI-04711 | Phoenix Biotechnology | Pre-clinical |
| Immunology Program | Ignite Biomedical | Discovery |